Past, present, and future of insulin pump therapy: Better shot at diabetes control

Mount Sinai Journal of Medicine

Volumn 75, Issue 4, 2008, Pages 352-361

  Sherr, Jennifer ^a   Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous subcutaneous insulin infusion; Insulin pumps; Multiple daily injections; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING DRUG;

ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CHILD CARE; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE DURATION; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; EVENING DOSAGE; EXERCISE; GLYCEMIC CONTROL; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MORNING DOSAGE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; SCREENING TEST;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 52649178963     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20055     Document Type: Article

References (76)

1. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573-578.
2. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1978; 1: 204-207.
3. Home PD, Pickup JC, Keen H, et al. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Metabolism 1981; 30: 439-442.
4. Lauritezen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983; 24: 326-329.
5. Amiel SA, Tamborlane WV, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med 1987; 316: 1376-1383.
6. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37: 901-907.
7. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 1992; 41: 255-260.
8. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The Diabetes Control and Complications Trial. N Engl J Med 1993; 329: 977-986.
9. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.
10. DCCT/EDIC Research Group. Beneficial effects of intensive therapy of diabetes during adolescence outcomes after the conclusion of the Diabetes Control and Complications Trial. J Pediatr 2001; 139: 804-812.
11. Boland, EA, Grey M, Oesterle A, et al. Continuous subcutaneous insulin infusion: a new way to achieve strict metabolic control, decrease severe hypoglycemia and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22: 1779-1784.
12. Ahern JA, Boland EA, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002; 3: 10-15.
13. Maniatis AK, Klingensmith GJ, Slover RH, et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107: 351-356.
14. Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol 2003; 16: 393-399.
15. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 1142-1146.
16. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus. J Pediatr 2003; 143: 796-801.
17. Alemzadeh, R, Ellis JN, Holzum MK, et al. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. J Pediatr 2004; 114: e91-e95.
18. Weinzimer SA, Ahern JA, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. J Pediatr 2004; 114: 1601-1604.
19. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 2005; 6: 17-21.
20. Schiaffini R, Ciampalini P, Spera S, et al. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005; 21: 347-352.
21. Jeha GS, Karaviti LP, Anderson B, et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005; 7: 876-884.
22. Nimri R, Weintrob N, Benzaquen H, et al. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. J Pediatr 2006; 117: 2126-2131.
23. Berhe T, Postellon D, Wilson B, Stone R. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. J Pediatr 2006; 117: 2132-2137.
24. Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med 2006; 23: 900-906.
25. Scrimgeour L, Cobry E, McFann K, et al. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 2007; 9: 421-428.
26. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26: 1079-1087.
27. Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin, and continuous subcutaneous infusion of insulin lispro. Diabetes 2000; 49: 2142-2148.
28. Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006; 7: 25-31.
29. De Beufort CE, Houtzagers CM, Bruinino GJ, et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two year follow up of a randomized prospective trial. Diabet Med 1989; 6: 766-771.
30. Ramachandani, N, Ten S, Anhalt H, et al. Insulin pump therapy from the time of diagnosis of type 1 diabetes. Diabetes Technol Ther 2006; 8: 663-670.
31. Springer D, Dziura J, Tamborlane WV, et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr 2006; 149: 227-232.
32. DeVries J, Snoek F, Kostense P, Masurel N. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002; 25: 2074-2080.
33. Weintrob, N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003; 112: 559-564.
34. Hoogma R, Hammon P, Gomist R, et al., for the 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5 Nations Trial. Diabet Med 2006; 23: 141-147.
35. DiMeglio L, Pottorff T, Boyd S, et al. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004; 145: 380-384.
36. Wilson P, Buckingham B, Kunzelman E, et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005; 28: 15-19.
37. Fox L, Buckloh L, Smith S, et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005; 28: 1277-1281.
38. Opipari-Arrigan L, Fredericks EM, Burkhart N, et al. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabetes 2007; 8: 377-383.
39. Sullivan-Bolyai S, Knafl K, Tamborlane W, Grey M. Parents' reflections on managing their children's diabetes with insulin pumps. J Nurs Sch 2004; 36: 316-323.
40. Pickup J, Matock M, Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomized controlled trials. BMJ 2002; 324: 1-6.
41. Doyle E, Weinzimer S, Steffen A, et al. A randomized, prospective trail comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27: 1554-1558.
42. Schiaffini R, Patera P, Bizzarri C, et al. Basal insulin supplementation in type 1 diabetic children: a long term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. J Endocrinol Invest 2007; 30: 572-577.
43. Chase HP, Dixon B, Pearson J, et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003; 143: 737-740.
44. Kaplan W, Rodriguez L, Smith O, et al. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004; 27: 2739-2740.
45. Tamborlane W, Sherwin R, Genel M, Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 1980; 68: 190-196.
46. Pickup J, Keen H, Viberti G, Bious R. Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. Br Med J 1981; 282: 766-768.
47. Renner R, Pfutzner A, Trautmann M, et al., for the German Humalog CSII Study Group. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care 1999; 22: 784-788.
48. Weinzimer S, Ternand C, Howard C, et al., for the Insulin Aspart Pediatric Pump Study Group. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care 2008; 31: 210-215.
49. Swan, K, Weinzimer S, Dziura J, et al. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008; 31: 44-46.
50. Catargi B, Breilh D, Gin H, et al. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps. Diabetes Metab 2001; 27: 323-327.
51. Pankoska E, Skorka A, Szypowska A, Lipka M. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes. Diabetes Technol Ther 2005; 7: 308-314.
52. Burdick J, Chase H, Slover R, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004; 113: e221-e224.
53. Chase H, Horner B, McFann K, et al. The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control. Diabetes Care 2006; 29: 1012-1015.
54. Diabetes Research in Children Network Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes. J Pediatr 2005; 147: 528-534.
55. Diabetes Research in Children Network Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006; 29: 20-25.
56. Diabetes Research in Children Network Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006; 29: 2200-2204.
57. Tamborlane W. Triple jeopardy: nocturnal hypoglycemia after exercise in the young with diabetes. JCEM 2007; 92: 815-816.
58. Weissberg-Benchell J, Goodman S, Antisdel Lomaglio J, Zebracki K. The use of continuous subcutaneous insulin infusion (CSII): parental and professional perceptions of self-care mastery and autonomy in children and adolescents. J Pediatr Psychol 2007; 32: 1196-1202.
59. Nicoucci A, Malone A, Franciosis M, et al. Quality of life and treatment satisfaction in adults with type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008; 25: 213-220.
60. Patton S, Dolan L, Henry R, Powers S. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion. Pediatr Diabetes 2007; 8: 362-368.
61. DCCT Research Group. Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care 1995; 18: 1468-1478.
62. Huo B, Steffen A, Swan K, et al. Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care 2007; 30: 362-363.
63. Melzer S, Richards G, Covington M. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable? Pediatr Diabetes 2004; 5: 133-142.
64. Ahern J, Ramcahndani N, Cooper J, et al. Using a primary nurse manager to implement DCCT recommendations in a large pediatric program. Diabetes Educ 2000; 26: 990-994.
65. Eugster E, Francis G, and the Lawson-Wilkins Drug and Therapeutics Committee. Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006; 118: e1244-e1249.
66. Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007; 30: 1653-1662.
67. Tamborlane W, Fredrickson L, Ahern J. Insulin pump therapy in childhood diabetes mellitus. Guidelines for use. Treat Endocrinol 2003; 2: 11-21.
68. Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858-1862.
69. Diabetes Research in Children Network Study Group. A randomized multicenter trial comparing the GlucoWatch biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28: 1101-1106.
70. Sachedina N, Pickup J. Performance assessment of the Medtronic-Minimed continuous glucose monitoring system and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 2003; 20: 1012-1015.
71. Diabetes Research in Children Network Study Group. Accuracy of the modified continuous glucose monitoring system sensor in an outpatient setting: results from a Diabetes Research in Children Network (DirecNet) study. Diabetes Technol Ther 2005; 7: 109-114.
72. Wilson D, Beck R, Tamborlane W, et al., and the DirecNet Study Group. The accuracy of the Freestyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007; 30: 59-64.
73. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111: 933-938.
74. Diabetes Research in Children Network Study Group. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007; 151: 388-393.
75. Panteleon A, Loutseiko M, Steil G, Rebrin K. Evaluation of the effect of gain on meal response of an automated closed-loop insulin delivery system. Diabetes 2006; 55: 1995-2000.
76. Weinzimer S, Steil G, Swan K, et al. Fully automated closed loop insulin delivery vs. semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008; 31: 934-939.